Ticker
VVOSCompany Name
VIVOS THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 26.03M | $ 4.4M | 16.91% |
3/31/2025 | $ 11.28M | $ 2.34M | 20.76% |
12/31/2024 | $ 15.28M | $ 6.26M | 40.96% |
9/30/2024 | $ 15.35M | $ 6.31M | 41.12% |
6/30/2024 | $ 15.84M | $ 6.9M | 43.57% |
3/31/2024 | $ 11.8M | $ 2.61M | 22.12% |
12/31/2023 | $ 10.73M | $ 1.64M | 15.31% |
9/30/2023 | $ 10.32M | $ 988K | 9.58% |
6/30/2023 | $ 13.75M | $ 3.94M | 28.67% |
3/31/2023 | $ 17.1M | $ 7.05M | 41.2% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for VIVOS THERAPEUTICS INC is calculated as follows: CashnEq [ $ 751.59K ] / Assets [ $ 7.55M ]
(=) Cash to Assets [ 9.95% ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |